Author(s):
David Power
Added:
3 months ago
Outcomes investigating the Absorb bioresorbable vascular scaffold (BVS) in patients undergoing percutaneous coronary intervention showed more adverse ischaemic events through 5 years compared with cobalt-chromium everolimus-eluting stents. However, the period of excess risk ended at 3 years.In this short interview, Dr David Power (Mount Sinai Hospital, New York, US) discusses the final report…
View more
Author(s):
Sean Lyden
Added:
3 months ago
LINC Conference 2025 - 30 day results of the PATCH study suggests the PerQSeal vascular closure device (Vivasure Medical Limited) can be used as an alternative percutaneous procedure for large-bore common femoral access, showing low risk of haematoma and a medium time of 0 minutes to achieve vessel closure.Dr Sean Lyden (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the PATCH single…
View more
Author(s):
David Power
Added:
1 year ago
CRT 24 - We are joined in this short virtual interview by investigator, Dr David Power (Mount Sinai Hospital, US) to discuss the latest findings from the ABSORB trial series, revealed in 2024 at the CRT conference.ABSORB III is a prospective, randomized, single-blind, multicenter trail aiming to support the pre-market approval of the Absorb bioresorbable vascular scaffold (Abbott) for the…
View more
Job title: Clinical Vascular Scientist
Dr Fabrizio D'Abate leads the sonography team at the UK Vein Clinic, and is a Clinical Vascular Scientist atSt George's University Hospital in London, UK. He is also Co-Founder of ABCvascular, an e-learning platform in vascular ultrasound. In 2022, Dr D'Abate founded LampoVet, a veterinary telemedicine platform.
Dr D'Abate completed his MSc in vascular ultrasound in Florence in 2007, before…
View more
Job title: Director of the Division of Cardiology
Dr Philip J Devereaux is the Director of the Division of Cardiology at McMaster University. He is also the Scientific Leader of the Anesthesiology, Perioperative Medicine, and Surgical Research Group at the Population Health Research Institute. Dr. Devereaux is a full Professor and University Scholar in the Departments of Health Research Methods, Evidence, and Impact (HEI) and Medicine at…
View more
Job title: Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust
Presenter
Prof Ajjan is a Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. He runs a programme of basic, translational and clinical research studies with…
View more
Author(s):
Dirk-Jan van Ginkel
Added:
8 months ago
ESC Congress 2024 — No benefit of continuing oral anticoagulation during TAVI procedure.Investigator, Dr Dirk-Jan van Ginkel (St Antonius Hospital, NL) joins us to discuss the result of the POPular PAUSE TAVI trial (NCT04437303; St Antonius Hospital). Presented for the first time at ESC 2024, this multicenter, randomized, open-label clinical trial compared the safety and efficacy of continuous…
View more